Drug Shortage Report for SPRYCEL

Last updated on 2019-01-22 History
Report ID 69624
Drug Identification Number 02360829
Brand name SPRYCEL
Common or Proper name Dasatanib 140mg
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) DASATINIB
Strength(s) 140MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 BTL x 30
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-01-21
Actual start date 2019-01-21
Estimated end date 2019-01-21
Actual end date 2019-01-21
Shortage status Resolved
Updated date 2019-01-22
Company comments Orders are being monitored / allocated. No other strengths are impacted.
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-12-14 English Compare
v2 2018-12-14 French Compare
v3 2019-01-05 English Compare
v4 2019-01-05 English Compare
v5 2019-01-05 French Compare
v6 2019-01-10 English Compare
v7 2019-01-10 French Compare
v8 2019-01-11 English Compare
v9 2019-01-11 French Compare
v10 2019-01-18 English Compare
v11 2019-01-18 English Compare
v12 2019-01-18 English Compare
v13 2019-01-18 French Compare
v14 2019-01-22 English Compare

Showing 1 to 14 of 14